PMV Pharmaceuticals, Inc. announced the appointment of Dr. Leila Alland, M.D., as Chief Medical Officer. Dr. Alland brings over 25 years of experience in oncology to the leadership of PMV Pharma. Dr. Alland will apply her considerable experience in oncology drug development to the leadership of PMV Pharma. Dr. Alland was most recently Chief Medical Officer at Affimed, where she built the clinical team and led the development of several programs. During her career, Dr. Alland held leadership positions at Tarveda Therapeutics, AstraZeneca, Bristol-Myers Squibb, Novartis and Schering-Plough, where she contributed to multiple successful drug approvals.